Program Urges Increased Cancer Data Sharing
Stakeholders of Project Data Sphere authored a Sounding Board article in the New England Journal of Medicine urging the responsible sharing of cancer trial data with global researchers.
In an example of the continued push among industry, academia, government, and hospitals to share more clinical research data, stakeholders of Project Data Sphere, LLC (PDS), a non-profit initiative of the CEO Roundtable on Cancer's Life Sciences Consortium, authored a Sounding Board article in this week’s New England Journal of Medicine urging the responsible sharing of cancer trial data with global researchers. Allowing researchers direct data access, the authors say, is critical to eliminating siloes and expanding discoveries and learnings in oncology R&D for the benefit of patients.
To that end, PDS has its own open-access cancer data platform, housing a free digital library of data. The platform, launched in 2014, allows researchers to download, share, integrate, and analyze patient data, while keeping patient anonymity intact. Presently, the platform includes 72 datasets resulting from nearly 42,000 patient lives, and PDS intends to expand the data and optimize the sharing of learned resources for trial participants. The platform can be found here: www.ProjectDataSphere.org
The CEO Roundtable on Cancer, comprised of top leaders from more than 30 U.S. companies, was founded by President Bush in 2001.
Unlock Commercial Growth through Data-Driven Patient and HCP Insights
May 2nd 2025Leveraging data-driven patient and healthcare provider (HCP) insights, including social drivers of health (SDOH), is essential for life sciences companies to continuously improve patient engagement and commercial success. Mark Rodgers, AVP of Commercial Analytics at Inovalon, discusses how identifying treatment milestones, assessing HCP performance, and segmenting patient populations using SDOH data can drive targeted strategies that improve healthcare outcomes and market access
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
FDA Approves Nipocalimab for the Treatment of Generalized Myasthenia Gravis
April 30th 2025Approval is based on results from the pivotal Vivacity-MG3 trial in which IMAAVY (nipocalimab-aahu) demonstrated superior disease control throughout 24 weeks when compared to placebo plus standard of care.
